Search Results - "Nakai, D."

Refine Results
  1. 1

    Inhibition of human organic anion transporter 3 mediated pravastatin transport by gemfibrozil and the metabolites in humans by Nakagomi-Hagihara, R., Nakai, D., Tokui, T.

    Published in Xenobiotica (01-04-2007)
    “…Coadministration of gemfibrozil (600 mg, b.i.d., 3 days) with pravastatin (40 mg/day) decreased the renal clearance of pravastatin by approximately 40% in…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Gemfibrozil and its glucuronide inhibit the hepatic uptake of pravastatin mediated by OATP1B1 by Nakagomi-Hagihara, R., Nakai, D., Tokui, T., Abe, T., Ikeda, T.

    Published in Xenobiotica (01-05-2007)
    “…When pravastatin (40 mg/day) was co-administered with gemfibrozil (600 mg, b.i.d., 3 days) to man, the AUC of pravastatin increased approximately 2-fold. We…”
    Get full text
    Journal Article
  4. 4

    Molecular characterization and functional regulation of a novel rat liver-specific organic anion transporter rlst-1 by Kakyo, Masayuki, Unno, Michiaki, Tokui, Taro, Nakagomi, Rie, Nishio, Toshiyuki, Iwasashi, Hajime, Nakai, Daisuke, Seki, Makoto, Suzuki, Masanori, Naitoh, Takeshi, Matsuno, Seiki, Yawo, Hiromu, Abe, Takaaki

    Published in Gastroenterology (New York, N.Y. 1943) (01-10-1999)
    “…Background & Aims: Recently, we isolated a new complementary DNA (cDNA) encoding human liver-specific organic anion transporter (LST-1), representing the…”
    Get full text
    Journal Article
  5. 5

    Cellular uptake mechanism for oligonucleotides: involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15 by Nakai, D, Seita, T, Terasaki, T, Iwasa, S, Shoji, Y, Mizushima, Y, Sugiyama, Y

    “…We used a 20-mer antisense oligonucleotide against human MDR1 mRNA to study the mechanism of uptake of oligonucleotides by a human colorectal adenocarcinoma…”
    Get more information
    Journal Article
  6. 6

    Design and synthesis of oatp subtype-specific antisense oligonucleotides having 2′-O,4′-C-ethylene-bridged nucleic acids (ENA™) by Takagi, Miho, Morita, Koji, Nakai, Daisuke, Nakagomi, Rie, Tokui, Taro, Koizumi, Makoto

    Published in Nucleic Acids Symposium Series (01-09-2003)
    “…To select antisense oligonucleotides (AONs) that specifically target the genes of rat organic anion transporting polypeptide (oatp) subtypes, in vitro…”
    Get full text
    Journal Article
  7. 7

    T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice by Terasaka, Naoki, Hiroshima, Ayano, Koieyama, Tadashi, Ubukata, Naoko, Morikawa, Yuka, Nakai, Daisuke, Inaba, Toshimori

    Published in FEBS letters (11-02-2003)
    “…Liver X receptors (LXRα and LXRβ) are nuclear receptors, which are important regulators of cholesterol and lipid metabolism. LXRs control genes involved in…”
    Get full text
    Journal Article
  8. 8

    Evaluation of the efficiency of targeting of antitumor drugs: simulation analysis based on pharmacokinetic/pharmacodynamic considerations by Nakai, D, Fuse, E, Suzuki, H, Inaba, M, Sugiyama, Y

    Published in Journal of drug targeting (1996)
    “…Antitumor drugs can be classified into two groups; cell cycle phase nonspecific (type I) and specific (type II) drugs. The cytotoxic activity of type I drugs…”
    Get more information
    Journal Article
  9. 9

    Identification of an autonomous transactivation domain in helix H3 of the vitamin D receptor by Kraichely, Dennis M., Nakai, Yuichiro D., MacDonald, Paul N.

    Published in Journal of cellular biochemistry (01-10-1999)
    “…The vitamin D receptor (VDR) contains an α‐helical, ligand‐inducible activation function (AF‐2) at the COOH‐terminus of the ligand‐binding domain (LBD). In…”
    Get full text
    Journal Article
  10. 10

    Structure-based targeting of bioactive proteins into cypovirus polyhedra and application to immobilized cytokines for mammalian cell culture by Ijiri, Hiroshi, Coulibaly, Fasséli, Nishimura, Gento, Nakai, Daisuke, Chiu, Elaine, Takenaka, Chiemi, Ikeda, Keiko, Nakazawa, Hiroshi, Hamada, Norio, Kotani, Eiji, Metcalf, Peter, Kawamata, Shin, Mori, Hajime

    Published in Biomaterials (01-09-2009)
    “…Abstract Certain insect viruses produce stable infectious micro-crystals called polyhedra which function to protect the virus after the death of infected…”
    Get full text
    Journal Article
  11. 11

    OATP1B1, OATP1B3, AND MRP2 ARE INVOLVED IN HEPATOBILIARY TRANSPORT OF OLMESARTAN, A NOVEL ANGIOTENSIN II BLOCKER by NAKAGOMI-HAGIHARA, Rie, NAKAI, Daisuke, KAWAI, Kenji, YOSHIGAE, Yasushi, TOKUI, Taro, ABE, Takaaki, IKEDA, Toshihiko

    Published in Drug metabolism and disposition (01-05-2006)
    “…Hepatic uptake and biliary excretion of olmesartan, a new angiotensin II blocker, were investigated in vitro using human hepatocytes, cells expressing uptake…”
    Get full text
    Journal Article
  12. 12

    Identification of a Novel Gene Family Encoding Human Liver-specific Organic Anion Transporter LST-1 by Abe, T, Kakyo, M, Tokui, T, Nakagomi, R, Nishio, T, Nakai, D, Nomura, H, Unno, M, Suzuki, M, Naitoh, T, Matsuno, S, Yawo, H

    Published in The Journal of biological chemistry (11-06-1999)
    “…We have isolated a novel liver-specific organic anion transporter, LST-1, that is expressed exclusively in the human, rat, and mouse liver. LST-1 is a new gene…”
    Get full text
    Journal Article
  13. 13

    Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes by Nakai, D, Nakagomi, R, Furuta, Y, Tokui, T, Abe, T, Ikeda, T, Nishimura, K

    “…Involvement of LST-1 (a human liver-specific transporter, also called OATP2) as the major transporter in the uptake of pravastatin, a…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Evaluation of the protein binding ratio of drugs by a micro-scale ultracentrifugation method by Nakai, Daisuke, Kumamoto, Kazuyo, Sakikawa, Chisa, Kosaka, Toshiyuki, Tokui, Taro

    Published in Journal of pharmaceutical sciences (01-04-2004)
    “…Ultracentrifugation methods have been widely used for the determination of the free fraction of compounds in plasma, especially for lipophilic compounds. To…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18

    Un-cooled operation (10°C to 85°C) of a 10.7-Gbit/s 1.55-μm electro- absorption modulator integrated DFB laser for 40-km transmission by Sasada, N, Naoe, K, Sakuma, Y, Washino, R, Nakai, D, Motoda, K, Makino, S, Shinoda, K, Shiota, T, Kitatani, T, Fukamachi, T, Aoki, M

    “…A modulated output-power more than +3.7 dBm, a dynamic extinction-ratio over 9.3 dB, and a power- penalty below 1.8 dB were achieved for 10.7-Gbit/s, 40-km…”
    Get full text
    Conference Proceeding
  19. 19
  20. 20

    Pravastatin, an HMG-CoA reductase inhibitor, is transported by rat organic anion transporting polypeptide, oatp2 by TOKUI, T, NAKAI, D, NAKAGOMI, R, YAWO, H, ABE, T, SUGIYAMA, Y

    Published in Pharmaceutical research (01-06-1999)
    “…We previously demonstrated the HMG-CoA reductase inhibitor, pravastatin, is actively taken up into isolated rat hepatocytes through multispecific organic anion…”
    Get full text
    Journal Article